erlotinib hydrochloride - medicine shortage information
Back to ALL shortages and discontinuations Back to CRITICAL shortages and discontinuations
If you are having difficulty obtaining a medicine that has been prescribed to you, talk to your doctor or pharmacist to discuss suitable options to continue your care.
More information about medicine shortages and how to access alternative medicines is available at the Medicine Shortages hub
Product details |
Supply Impact Dates |
Further Details |
TARCEVA erlotinib 100 mg tablet blister pack AUST R: 114717Active ingredients:
erlotinib hydrochloride
Dosage form: Tablet, film coated
Sponsor: Roche Products Pty Ltd
Phone: 1800 233 950
|
Deletion from market:
31 Jul 2023
|
Shortage status: Discontinued
Availability: Unavailable
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products available
|
TARCEVA erlotinib 150 mg tablet blister pack AUST R: 114721Active ingredients:
erlotinib hydrochloride
Dosage form: Tablet, film coated
Sponsor: Roche Products Pty Ltd
Phone: 1800 233 950
|
Deletion from market:
31 Mar 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products available
|
TARCEVA erlotinib 25 mg tablet blister pack AUST R: 114714Active ingredients:
erlotinib hydrochloride
Dosage form: Tablet, film coated
Sponsor: Roche Products Pty Ltd
Phone: 1800233950
|
Deletion from market:
29 Feb 2024
|
Shortage status: Discontinued
Availability: Reduction in supply until supply is exhausted
Reason: Commercial Changes / Commercial viability
Management action: Alternative generic products available
|